Trial of Pembrolizumab and Radiotherapy in Melanoma

NCT02562625 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Slow Recruitment

Conditions

Melanoma

Interventions

DRUG: Pembrolizumab
RADIATION: Radiotherapy

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]
[object Object]